drugset / Trial / NCT05587257

Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

NCT05587257

Unknown 60 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

* Compare the clinical efficacy, and safety of transepidermal drug delivery of fractional CO2 laser versus microneedling followed by minoxidil 5% application for the treatment of alopecia areata. * Evaluate the efficacy, and safety of minoxidil nanoparticles as a topical treatment of alopecia areata.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2024-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minoxidil Small molecule 5 % Topical

Indications